INTRODUCTION
The whole genome sequence of Helicobacter pylori strain 51 (Korean isolate) has been previously reported (1) .
Far Eastern countries, including Korea, Japan, and China, demonstrate the highest worldwide prevalence of H. pylori infection. Consequently, these countries also have the highest incidence of gastroduodenal disorders, including gastric cancers (2~4). In the gram-negative bacteria, many surfaceexposed proteins are constituents of the outer membrane (OM), which forms a barrier between the cell and its surroundings. The OM performs a structural function, and also performs a major role in determining what enters the cell, what molecules are secreted from the cell, and how the cell interacts with its environment. The OM is rich in transmembrane proteins, the functions of which include motility in transporting nutrients to and from the cells, conjugation, and the control of cell morphology (5) . Interest has been increasing in the role of H. pylori outer membrane proteins (OMPs) in gastroduodenal diseases, and new findings have been reported in relation to OMPs and clinical outcomes and gastric histology (6) . However, little is currently known concerning the OMPs of H. pylori or the identities of them. Only a few proteins have been identified thus far as being unambiguously localized within the OM (7, 8) . In an effort to confirm the predicted surface proteins and to identify additional candidates, proteome analysis is a particularly appropriate method. The OM of H. 103 pylori is quite difficult to isolate without inner membrane contamination, and appears to be strongly associated with the inner membrane. In order to enrich surface proteins for proteome analysis and to avoid potential problems with contamination from the inner membrane and the cytoplasm, H. pylori was treated with sarcosine (9) and subsequently analyzed via 2-DE, via which potential surface proteins were detected. These findings could contribute to new proteome analysis applications and to the construction of the OMP 2-DE map of the H. pylori strain.
In this study, on the basis of the genomic sequencing information for H. pylori OMP annotation, the major proteome components of H. pylori strain 51 were analyzed.
Our findings may prove useful in elucidating the biological functions of the Korean strain H. pylori 51, and would therefore also prove useful in diagnostics and vaccine development.
MATERIALS & METHODS

Bacterial strain and growth condition
H. pylori strain 51 was isolated from a Korean patient with a duodenal ulcer. H. pylori strain 51 was stored in a liquid nitrogen tank, and then thawed and incubated onto a brucella agar plate containing 10% bovine serum, vancomycin (6.9 μM), and amphotericin B (1. 
Sarcosine preparation of H. pylori OMPs
The sarcosine-insoluble outer membrane fraction of H. pylori was prepared as described previously (9) 
Silver staining
Silver staining was followed by the method developed by Heukeshoven et al (10) with slight modifications. In brief, the gels were fixed for 90 min with fixing solution containing 50% methanol, 12% acetic acid, and 0.5 ml 37% formaldehyde/L. All incubation was conducted in a shaker with gentle shaking. After fixing, the gels were washed twice for 20 min each with 50% ethanol, and then washed for an additional 20 min with dDW. The gels were pre-treated for 1 min with Na 2 S 2 · 5H 2 O (0.1 g/L) and again washed with dDW. Silver nitrate was impregnated via 30 min of incubation in AgNO 3 (2 g/L) and 0.75 ml 37% HCOH/L, and then rinsed three times with dDW for 20 sec each. Visualization was conducted by incubation in developing solution until a clear image emerged. The solution consisted of Na 2 CO 3 (60 g/L), Na 2 S 2 · 5H 2 O (0.2 g/ L) and 0.5 ml 37% HCOH, which was prepared previously and preserved in an ice slurry. When clear spots emerged, the gel was washed twice with dDW for 20 sec each, and then the reaction was halted via the addition of 50% MetOH and 12% AcOH for 10 min. 
Spot processing for nanoelectrospray MS/MS
The silver-stained proteins were destained with the chemical reducers to remove the silver and tryptic digestion was conducted via the method previously described by O'Connell & Stults (11, 12) Da in the masses of both precursor and product ions was selected.
RESULT
We performed proteome analysis of H. pylori strain 51 via nanoelectrospray MS/MS. The sarcosine-insoluble protein solution of the strain was loaded onto IPG strips with a pH gradient ranging from 6.0 to 11.0 for the firstdimension separation. The strips were then loaded onto 12.5% acrylamide gel for the second-dimensional electrophoresis. After running SDS-PAGE, the separated spots were visualized via silver staining. The most abundant protein spots were enriched in the alkaline pI regions, and their molecular weights were measured in a range between approximately 10~100 kDa.
As is shown in Figure 1 , the silver-stained spots generated by 2-DE using the IPG strips of pH 6.0~11.0 were numbered, excised, and destained, followed by in-gel digestion with trypsin for peptide fingerprinting. The masses of the resultant peptide mixtures were measured via Q-TOF-MS.
Among the protein spots processed, 15 were identified as significant, including the putative OMPs, KHP0852, KHP-0853, KHP1353, KHP1017, KHP0172, KHP0076, KHP-0617, KHP1069, and KHP0614, as shown in Table 1 . The identified spots corresponded to 9 genes. The gel-estimated pI values corresponded strongly to the theoretical values of the protein spots, whose pI values were alkaline. However, some protein spots exhibited slight variations between the gel-estimated values and the calculated ones.
DISCUSSION
The proteome analysis technique has developed as the result of the broad availability of whole genome sequences of a number of bacterial species (14, 15) . It has also been suggested that new targets must be explored for the further development of diagnosis, treatment, and prevention of H.
pylori infections. Proteome analysis could prove an effective complement for genome-based investigation techniques for the determination of bacterial targets, and may also provide with a better understanding of the holistic biology of H.
pylori.
A Q-TOF mass spectrometer was used to identify proteins separated by one-dimensional or two-dimensional gel electrophoresis at the femtomolar level. The high mass OMPs was reported recently (16) . This study discussed the identification of 62 proteins from H. pylori strain 26695.
Our results addressed the homology of the H. pylori strain 26695 proteins addressed in the previous study. We identified an additional 13 protein spots, which could contribute to the extension of proteome analysis and might also help to elucidate their potential roles in the pathogenesis of this strain.
It has been previously suggested that the genome of H. pylori strain 51 theoretically encodes for 1,454 ORFs (1).
However, the total number of protein spots generated via 2-DE may be more than theoretical ORFs, as a number of proteins can be processed by proteolytic enzymes or modified via methylation, glycosylation, and phosphorylation (18~21). In this study, the sarcosine-insoluble proteins of H. pylori strain 51 evidenced more than 20 silverstained spots in the 2-DE gel using an IPG strip (17 cm) of pH 6.0~11.0 when analyzed using PDQUEST 2-D Gel Analysis Software. The majority of the protein spots were positioned in the alkaline pI regions and their molecular weights were between 10~100 kDa. H. pylori OMPs were detected within the alkaline pI region of the 2-DE gel. This may be reflective of evolutionary pressure for high alkaline proteins, owing to the acidic environment of the organism (16) . Among the 20 protein spots processed in this study, some spots did not generate apparent spectra on Q-TOF-MS.
The spectra of several protein spots could not be generated on Q-TOF-MS, even though they exhibited intense spots. modification may be one possible cause for these discrepancies. Differences between the gel-estimated and theoretical pI values were larger than those between the gelestimated and theoretical molecular weights, thus indicating that processing and modification may affect the pI values of proteins (14) .
In this study, we identified 15 protein spots corresponding to 9 genes, as shown in Table 1 . Among the 30 spots, 4 horizontally located spots (spot no 1, 2, 4, 5) were identified as a KHP0853 homologous to OMP21 in H. pylori 26695.
KHP0852 and KHP1353 are homologous to OMP20 and OMP32, respectively. KHP1017 was identified as a γglutamyltranspeptidase (GGT), an enzyme that catalyzes the transpeptidation reaction in which a γ-glutamyl moiety is transferred from γ-glutamyl compounds, such as glutathione and glutathione-conjugated compounds, to amino acids and a protein of 61 KDa, although the observed value (38 KDa) was smaller than anticipated. Mature GGT is a heterodimer (38 KDa + 20 KDa) and a periplasmic enzyme, suggesting that the spot may represent the large subunit of this periplasmic protein (22) . KHP 0172 was identified as cell binding factor 2, located in the OM. Two horizontally located spots (spot no 21, 22) were identified as a hypothetical protein (KHP1069) homologous to HP1173 in H. pylori 26695. HP1173 is secreted into the extracellular medium and was identified previously as an immunoreactive protein (23) .
Additionally, KHP0614 was identified as a hypothetical protein. However, the functions of this protein are not currently known. Some horizontally aligned spots were identified. This horizontal separation may be attributable to post-translational modifications that result in differentiallycharged side chains on the amino acid residues of one species of protein (24) .
In summary, certain proteins, including the putative OMPs, were identified by the enrichment of sarcosineinsoluble proteins from H. pylori 51. In this study, the identified proteins appeared to assume a pattern similar to that of H. pylori strain 26695, and the 9 genes may be major OMPs of H. pylori 51. Our results contribute substantially to the characterization of the OMPs of H. pylori 51, which will facilitate the identification of new potential target proteins of the Korean H. pylori strain 51 for vaccine development and drug therapy.
